| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 2.109 | 7.430 | 11.884 | 7.893 | 42.987 |
| Total Income - EUR | - | - | - | - | - | 2.109 | 7.430 | 11.960 | 66.735 | 134.813 |
| Total Expenses - EUR | - | - | - | - | - | 1.361 | 6.187 | 10.292 | 92.582 | 131.654 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 748 | 1.243 | 1.668 | -25.847 | 3.159 |
| Net Profit/Loss - EUR | - | - | - | - | - | 717 | 1.094 | 1.309 | -25.847 | 2.654 |
| Employees | - | - | - | - | - | 1 | 1 | 0 | 2 | 2 |
Check the financial reports for the company - Silosi Medical Tech S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 43.884 | 72.340 | 76.942 | 131.390 | 106.522 |
| Current Assets | - | - | - | - | - | 2.570 | 1.620 | 3.194 | 97.004 | 25.402 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 859 | 784 |
| Receivables | - | - | - | - | - | 1.884 | 165 | 897 | 87.380 | 15.767 |
| Cash | - | - | - | - | - | 687 | 1.455 | 2.297 | 8.765 | 8.851 |
| Shareholders Funds | - | - | - | - | - | 758 | 5.838 | 7.166 | -18.703 | -15.945 |
| Social Capital | - | - | - | - | - | 41 | 4.043 | 4.056 | 4.043 | 4.021 |
| Debts | - | - | - | - | - | 45.696 | 68.797 | 72.981 | 117.299 | 116.233 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 130.094 | 31.659 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6391 - 6391" | |||||||||
| CAEN Financial Year |
6312
|
|||||||||
Comments - Silosi Medical Tech S.r.l.